• Research/Demonstration Projects: Thailand has been the site of trials and demonstration projects of daily oral PrEP in men who have sex with men (MSM), transgender (TG) women, women and people who inject drugs. The Ministry of Public Health (MoPH) is conducting a demonstration project in MSM, linked to a test-and-treat study conducted by the Thai Red Cross, MoPH, USAID, GFATM, Rainbow Sky Association of Thailand and several others. The Thai Red Cross is implementing a PrEP 30 project for MSM and TG women in Bangkok.
  • Drug Registration: Truvada is registered for treatment and prevention.
  • Policy/Regulatory: There is no national PrEP policy or guidance at present. There is anecdotal evidence of interest in developing national guidance, as per the demonstration project by MoPH.
  • Advocacy: National Community Advisory Board, focused on biomedical HIV prevention research, has been actively pushing for PrEP introduction, especially following positive efficacy trial results of iPrEx and BTS—two randomized-controlled studies that had sites in Thailand. This group has links to national policy making bodies such as the National AIDS Committee and its sub-committee on biomedical HIV prevention research. It is comprised primarily of civil society representatives and is managed by the Thai NGO Coalition on AIDS. There is reported openness amongst potential PrEP users, especially the LGBT community. Stakeholder consultations are being proposed as part of regional Asia-focused efforts led by WHO, UNAIDS and APCOM. An analysis of acceptability among MSM in Asia is ongoing (see below): Preparing Asia—Tell Us What You Know about PrEP survey. You can also view short educational videos on PrEP from APCOM, as part of the regional dialogue "PrEPARING ASIA: A new direction for HIV prevention among MSM in Asia".

Last updated on September 1, 2017.

News Spotlight